Sign in

CIK 0001662774

  • Non-accelerated filer
  • Smaller reporting company

IRulya Therapeutics Inc.

Sign in to watch
Ticker
IRLA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
901024039
Phone
+1 203-208-8994
Business address
101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
Former names
Quince Therapeutics, Inc., Cortexyme, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-08-10 Detke Michael J. Chief Medical Officer Option exercise · Stock Option (right to buy) −10,000 92,352
2021-07-07 Detke Michael J. Chief Medical Officer Option exercise +17,400 $2.23 $39K 17,400
2021-07-07 Detke Michael J. Chief Medical Officer Sale −3,934 $53.24 $209K 13,466
2021-07-07 Detke Michael J. Chief Medical Officer Sale −1,648 $54.37 $90K 11,818
2021-07-07 Detke Michael J. Chief Medical Officer Sale −4,353 $55.38 $241K 7,465
2021-07-07 Detke Michael J. Chief Medical Officer Sale −6,942 $56.27 $391K 523
2021-07-07 Detke Michael J. Chief Medical Officer Sale −523 $56.99 $30K 0
2021-07-07 Detke Michael J. Chief Medical Officer Option exercise · Stock Option (right to buy) −17,400 102,352
2021-07-06 Detke Michael J. Chief Medical Officer Option exercise +12,600 $2.23 $28K 40,861
2021-07-06 Detke Michael J. Chief Medical Officer Sale −32,313 $53.43 $1.7M 8,548
2021-07-06 Detke Michael J. Chief Medical Officer Sale −8,260 $53.91 $445K 288
2021-07-06 Detke Michael J. Chief Medical Officer Sale −288 $55.01 $16K 0
2021-07-06 Detke Michael J. Chief Medical Officer Option exercise · Stock Option (right to buy) −12,600 119,752
2021-06-30 LOWE CHRISTOPHER P. COO & Chief Financial Officer Option exercise +30,000 $2.23 $67K 30,000
2021-06-30 LOWE CHRISTOPHER P. COO & Chief Financial Officer Option exercise · Stock Option (right to buy) −30,000 185,294
2021-06-28 LOWE CHRISTOPHER P. COO & Chief Financial Officer Option exercise +20,000 $2.23 $45K 20,000
2021-06-28 LOWE CHRISTOPHER P. COO & Chief Financial Officer Sale −7,724 $53.39 $412K 12,276
2021-06-28 LOWE CHRISTOPHER P. COO & Chief Financial Officer Sale −7,079 $54.13 $383K 5,197
2021-06-28 LOWE CHRISTOPHER P. COO & Chief Financial Officer Sale −4,153 $55.11 $229K 1,044
2021-06-28 LOWE CHRISTOPHER P. COO & Chief Financial Officer Sale −1,044 $56.16 $59K 0

Page 10 of 18 · 350 trades